Investor Presentation

Transcription

1 Investor Presentation October 2015 Jay Hoffman Chief Strategy Officer

2 Forward Looking Statements & Statutory Rights of Action FORWARD-LOOKING STATEMENTS Certain statements in this presentation (the "Presentation") may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Patient Home Monitoring Corporation and its predecessor companies ("PHM"), or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this Presentation, such statements use such words as "may", "will", estimate(d), "expect", "believe", "plan", "intend", "should", "anticipate" and other similar terminology. These statements reflect current assumptions and expectations regarding future events and operating performance and speak only as of the date of this Presentation. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward-looking statements, including, but not limited to, the risk factors typical of businesses operating in PHM's industry. Although the forwardlooking statements contained in this Presentation are based upon what management believes are reasonable assumptions, PHM cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this Presentation, and PHM assumes no obligation to update or revise them to reflect new events or circumstances. STATUTORY RIGHTS OF ACTION If this Presentation is delivered to you for the purpose of assisting you in making a decision about investing in securities of PHM and you decide to purchase such securities, this document may be considered an offering memorandum pursuant to securities laws applicable in the Province of Ontario. This means that if this Presentation contains a misrepresentation and it was a misrepresentation at the time of purchase of securities by you, you will be deemed to have relied upon the misrepresentation and will, as provided below, have a right of action against PHM for damages or, while still the owner of such securities, for rescission, provided: (a) an action is commenced to enforce such right: (i) in the case of an action for rescission, not more than 180 days after the date of purchase; or (ii) in the case of an action for damages, not more than the earlier of (i) 180 days following the date you first had knowledge of the misrepresentation and (ii) three years after the date of purchase; (b) PHM will not be liable if it proves that you purchased the securities with knowledge of the misrepresentation; (c) in the case of an action for damages, PHM will not be liable for all or any portion of the damages that it proves does not represent the depreciation in value of the securities as a result of the misrepresentation relied upon; and (d) in no case will the amount recoverable in any action exceed the price at which you purchased the securities. If you elect to exercise the right of rescission, then you will have no right of action for damages against PHM. The foregoing summary is subject to the express provisions of the Securities Act (Ontario) and the regulations, rules and policy statements thereunder and reference is made thereto for the complete text of such provisions. The rights of action described herein are in addition to and without derogation from any other right or remedy that you may have at law. 2

3 Who We Are Why Invest Future Direction

4 Improving our patients lives & reducing healthcare costs 450+ employees across 27 states delivering world class healthcare to patients across the spectrum of both acute and chronic illnesses. Our clinicians drive results through technology and collaborative care models that ultimately brings results such as: 93% of our patient report they breathe better 70+% improvement over average 30 day readmit rate 42% reduction in hospital readmission

5 The Target Market Roughly 10,000 Baby Boomers will turn 65 today, and about 10,000 more will cross that threshold every day for the next 19 years 26% of the total U.S. population are Baby Boomers 1 Readmissions cost the Medicare program $17.5 billion just in inpatient spending, or a 19.2% readmission rate on all Medicare patients % of people who have Chronic Obstructive Pulmonary Disease (COPD) are discharged from the hospital will be readmitted to the hospital within 30 days or less, and that many of these readmissions are preventable. 3 Health care spending in the U.S. is projected to have hit $3.1 trillion, or $9,695 per person, last year (2014)

6 Virtual Hospital in the Home Leading the Shift in Healthcare Delivery Current State Healthcare delivered within the institution Physician centered decisions centered around the hospital Pt. lack of healthcare knowledge Lack of home services/technology availability Fee for service Future State Patients demand healthcare in their homes A mix of patient, physician and payer driven decisions. Online and in-person education High availability of technology and services Outcomes based reimbursement 6

7 Who We Are Why Invest Future Direction

8 Why invest Industry Leading Management Team Strong Portfolio Broad range of clinical services and healthcare offerings In home Sleep and Coumadin testing End to End respiratory solutions Patient monitoring for varying degree of needs Twenty-seven states and growing in coverage Strong Performance Consistent solid revenue growth record Operational excellence is part of our DNA Strong cash flow Growth Drivers Rapid growth in an industry experiencing consolidation Addressing the fastest growing segment of healthcare Utilizing technology that scales the business with little investment

9 A Company with a Mission & Vision Mission Statement: To educate, nurture, and inspire our patients to live better lives. Vision Statement: We want to be THE healthcare company admired for its people, performance, and partnership!

10 Targeted diversified revenue sources DIVERSIFICATION Testing Retail Respiratory Current state of offerings Not reflective of potential of adjacent space acquisitions Sleep Complex Rehab

11 Strong financial performance Revenue Growth EBITDA Margin Growth Market Cap Growth $ Millions $ Millions

12 Who We Are Why Invest Future Direction

13 Operational Leadership Initiatives Business Integration Growth Talent Acquisition Financial Results 13

14 Business Integration Organizational changes to reflect a ONE PHM to our patients, our clinician base and the investor market Bringing Billing and Finance into the Lafayette, LA headquarters Consolidating, Purchasing, Operations, HR, Sales and Marketing groups into a hierarchal alignment Eliminating duplicating efforts throughout the organization

15 GROWTH Five Strategic Models Existing Business (organic) Add new service offerings 100k+ current active patients Leverage current assets Geographic Expansion New territories New States Population Health Emerging Care Models Accountable Care Org (ACO) Hospital based PPO/HMO Cash Acquisition More strategic approach New or complimentary services Adding more active patients Channel Expansion Retail E-commerce Partnerships PHM Investor Presentation - January

16 Talent acquisition Recruited and hired: Chief Medical Officer First ever established in this space Chief Information Officer Information systems and integration support Corporate Billing Manager Elevating the role of this position

17 Current Status of PHM Financial Results Exiting Q3 D Financial Metrics (rounded) o Annualized June 2015 Run Rate Revenues: $116 million o Approximately $56 million in cash as of August % Q4 Spending: o Centralization costs in Q4 include investments in common systems, consulting expenses and duplicated staffing o In addition, investing heavily in Q4 to support 2016 growth initiatives (hiring & training, marketing spending, startup facility costs) o Total Q4 investment to achieve the above expected to be $3 to $4 million with resulting benefits beginning in Q1, 2016 Pending Acquisition: o Announced acquisition of Patient Aids expected to close October 7, 2015 o Revenue of $20M and EBITDA margin of 35% 17

18 Target 2015 PHM Exit Revenue Run Rate Financial Results PHM Today: $125 million Revenue Add: $20 million Acquisition of Patient Aids Add: $10 million Organic growth of PHM in Oct Dec 15 (20% annual growth) 2015 PHM Exit Revenue Run Rate: $155 million (not including future acquisitions) Adjusted EBITDA margin: 23% - 28% * In calculating Adjusted EBITDA certain items are excluded from net loss including interest, taxes, amortization, non-cash stock-based compensation. 18

19 The Leadership Team D Casey Hoyt (CEO): Former CEO of Sleep Management with more than 15 years of executive management experience. Led Sleep Management to consistent year-overyear organic growth rates in excess of 100%. Mike Moore (President): Former President of Sleep Management with more than 15 years of healthcare clinician experience. Served previously as a Respiratory Therapist with several healthcare companies prior to Sleep Management including Praxair and Home Care Supply. Jay Hoffman (CSO): Over 30 years of healthcare and business experience including 17+ years with Philips HealthTech and Philips Respironics. Served in the capacities of V.P. of Sales, V.P. of Business Development and Sr. Director-Field Marketing. 19

20 Capital Structure Total Number of Shares Outstanding: 334,743,080 Insider/Management Holdings: 25% Market Cap as of October 5, 2015: $208.2 million 20

21 OUR INVESTOR PROPOSITION PHM is an organic growth engine complimented by its acquisitionorientation while being a profitable company offering patients with chronic health conditions home-based services in the US. PHM is acquiring companies in a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM has identified and is evaluating profitable, annuity-based companies to acquire at favorable prices for their patient databases and technical expertise. PHM's post-acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The result to date has been growing EPS with each acquisition and growing revenue and profits from enhanced upsell services across the patient base where they may not have existed before.

22 Contact Investor Relations Phone: (604) Website: